Biologically active phthalocyanine metal complexes: Preparation, evaluation of alpha-glycosidase and anticholinesterase enzyme inhibition activities, and molecular docking studies
Yazar
Taslimi, Parham
ERKAN, SULTAN
Taskin, Omer S.
Guzel, Emre
KOÇYİĞİT, ÜMİT MUHAMMET
Üst veri
Tüm öğe kaydını gösterÖzet
In this study, preparation, as well as investigation of alpha-glycosidase and cholinesterase (ChE) enzyme inhibition activities of furan-2-ylmethoxy-substituted compounds 1-7, are reported. Peripherally, tetra-substituted copper and manganese phthalocyanines (5 and 6) were synthesized for the first time. The substitution of furan-2-ylmethoxy groups provides remarkable solubility to the complex and redshift of the phthalocyanines Q-band. Besides, the inhibitory effects of these compounds on acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and alpha-glycosidase (alpha-Gly) enzymes have been investigated. The AChE was inhibited by these compounds (1-7) in low micromolar levels, and K-i values were recorded between 11.17 +/- 1.03 and 83.28 +/- 11.08 mu M. Against the BChE, the compounds demonstrated K-i values from 7.55 +/- 0.98 to 81.35 +/- 12.80 mu M. Also, these compounds (1-7) effectively inhibited alpha-glycosidase, with K-i values in the range of 744.87 +/- 67.33 to 1094.38 +/- 88.91 mu M. For alpha-glycosidase, the most effective K-i values of phthalocyanines 3 and 6 were with K-i values of 744.87 +/- 67.33 and 880.36 +/- 56.77 mu M, respectively. Moreover, the studied metal complexes were docked with target proteins PDB ID: 4PQE, 1P0I, and 3WY1. Pharmacokinetic parameters and secondary chemical interactions that play an active role in interaction were predicted with docking simulation results. Overall, furan-2-ylmethoxy-substituted phthalocyanines can be considered as potential agents for the treatment of Alzheimer's diseases and diabetes mellitus.
Koleksiyonlar
- Makale [92796]